New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants

Detalles Bibliográficos
Autores principales: Penezina, O, Clapham, D, Collins, J, Kovalenko, V, Krueger, N, Rodriguez-Chavez, IR, Busch, MP, Levin, AE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441408/
http://dx.doi.org/10.1186/1742-4690-9-S2-P120
_version_ 1782243282557861888
author Penezina, O
Clapham, D
Collins, J
Kovalenko, V
Krueger, N
Rodriguez-Chavez, IR
Busch, MP
Levin, AE
author_facet Penezina, O
Clapham, D
Collins, J
Kovalenko, V
Krueger, N
Rodriguez-Chavez, IR
Busch, MP
Levin, AE
author_sort Penezina, O
collection PubMed
description
format Online
Article
Text
id pubmed-3441408
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34414082012-09-18 New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants Penezina, O Clapham, D Collins, J Kovalenko, V Krueger, N Rodriguez-Chavez, IR Busch, MP Levin, AE Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441408/ http://dx.doi.org/10.1186/1742-4690-9-S2-P120 Text en Copyright ©2012 Penezina et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Penezina, O
Clapham, D
Collins, J
Kovalenko, V
Krueger, N
Rodriguez-Chavez, IR
Busch, MP
Levin, AE
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
title New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
title_full New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
title_fullStr New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
title_full_unstemmed New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
title_short New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
title_sort new hiv peptide-based immunoassay resolves vaccine-induced seropositivity in hiv vaccine (phase iii) trial participants
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441408/
http://dx.doi.org/10.1186/1742-4690-9-S2-P120
work_keys_str_mv AT penezinao newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants
AT claphamd newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants
AT collinsj newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants
AT kovalenkov newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants
AT kruegern newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants
AT rodriguezchavezir newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants
AT buschmp newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants
AT levinae newhivpeptidebasedimmunoassayresolvesvaccineinducedseropositivityinhivvaccinephaseiiitrialparticipants

Ejemplares similares